Compare ATEN & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEN | BHC |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2014 | 1996 |
| Metric | ATEN | BHC |
|---|---|---|
| Price | $31.29 | $4.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $26.33 | $8.00 |
| AVG Volume (30 Days) | 868.6K | ★ 1.6M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 0.17 | N/A |
| Revenue | $235,429,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $13.02 | $4.61 |
| Revenue Next Year | $10.82 | N/A |
| P/E Ratio | $192.00 | ★ N/A |
| Revenue Growth | ★ 2.36 | N/A |
| 52 Week Low | $16.52 | $4.61 |
| 52 Week High | $32.95 | $8.69 |
| Indicator | ATEN | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 30.90 |
| Support Level | $17.11 | $4.93 |
| Resistance Level | N/A | $6.31 |
| Average True Range (ATR) | 1.14 | 0.20 |
| MACD | 0.26 | -0.04 |
| Stochastic Oscillator | 73.51 | 2.99 |
A10 Networks Inc is a provider of secure application and network infrastructure solutions for enterprises and service providers across on-premises, hybrid cloud, and distributed environments. The company's offerings include application delivery and traffic management, distributed denial-of-service (DDoS) protection, application and API security, and centralized management. It serves customers across multiple industries, including telecommunications, technology, financial services, public sector, industrial, retail, gaming, and education. The majority of the company's revenue is derived from the sale of secure networking and cybersecurity solutions and related maintenance and support services.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.